Drugs / soy protein
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/21 trial | ||||||
| Phase 1/2 | NCT00067678 | Jul 2001 → Jun 2003 | diabetes mellitus, diabetic kidney disease | National Center for Complementary and Integrative Health (NCCIH) | Completed | No outcome recorded |
| Phase 31 trial | ||||||
| Phase 3 | NCT00004654 | Jan 1996 → ? | hereditary hemorrhagic telangiectasia | National Center for Research Resources (NCRR) | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | soy protein | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00067678 ↗ |
| Known as | soy protein isolate | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00004654 ↗ |
| Modality | Protein / enzyme biologic | “soy protein, a plant protein” NCT00067678 ↗ |